Past, present, and future of endovascular stroke therapies

被引：18

作者：

Taqi, M. A. ^{[1
]}

Vora, N. ^{[2
,5
]}

Callison, R. C. ^{[2
,5
]}

Lin, R. ^{[2
,3
,4
]}

Wolfe, T. J. ^{[1
]}

机构：

[1] Desert Reg Med Ctr, Inst Clin Orthoped & Neurosci, Palm Springs, CA USA

[2] St Louis Univ, Dept Neurol, St Louis, MO 63103 USA

[3] St Louis Univ, Dept Neurosurg, St Louis, MO 63103 USA

[4] St Louis Univ, Dept Radiol, St Louis, MO 63103 USA

[5] St Louis Univ, Dept Psychiat, St Louis, MO 63103 USA

来源：

NEUROLOGY | 2012年 / 79卷 / 13期

关键词：

ACUTE ISCHEMIC-STROKE; CEREBRAL-ARTERY STROKE; MECHANICAL THROMBECTOMY; RANDOMIZED-TRIAL; CLOT REMOVAL; MERCI TRIAL; III TRIAL; DEVICE; THROMBOLYSIS; RECANALIZATION;

D O I：

10.1212/WNL.0b013e31826959e5

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Endovascular therapy in the acute management of ischemic stroke has become more common with technologic advances, such as easier navigation into the intracranial circulation and improved treatment efficacy with the advent of revascularization devices. This select review outlines milestones in the application of endovascular therapy in acute ischemic stroke (AIS) and offers some insight into important factors influencing the future directions of endovascular AIS treatment. In particular, we discuss the evolution of endovascular devices for AIS and how ingenuity continues to offer novel treatments. With these advances, the future of endovascular AIS treatment is promising. Neurology (R) 2012;79 (Suppl 1):S213-S220

引用

页码：S213 / S220

页数：8

共 50 条

[21] Past, present, and future of microbiome-based therapies
Manrique, Pilar
Montero, Ignacio
Fernandez-Gosende, Marta
Martinez, Noelia
Cantabrana, Claudio Hidalgo
Rios-Covian, David
[J]. MICROBIOME RESEARCH REPORTS, 2024, 3 (02):
[22] Therapies to modulate gut microbiota:Past,present and future
Akshita Gupta
Srishti Saha
Sahil Khanna
[J]. World Journal of Gastroenterology, 2020, (08) : 777 - 788
[23] Antiinflammatory therapies for cystic fibrosis: Past, present, and future
Prescott, WA
Johnson, CE
[J]. PHARMACOTHERAPY, 2005, 25 (04): : 555 - 573
[24] The past, present, and future of enzyme-based therapies
Hennigan, Jennifer N.
Lynch, Michael D.
[J]. DRUG DISCOVERY TODAY, 2022, 27 (01) : 117 - 133
[25] Therapies to modulate gut microbiota: Past, present and future
Gupta, Akshita
Saha, Srishti
Khanna, Sahil
[J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (08) : 777 - 788
[26] Targeted therapies in hepatocellular carcinoma: past, present, and future
Gujarathi, Rushabh
Franses, Joseph W.
Pillai, Anjana
Liao, Chih-Yi
[J]. FRONTIERS IN ONCOLOGY, 2024, 14
[27] Past, Present, and Future of Targeting Ras for Cancer Therapies
Tan, Zhi
Zhang, Shuxing
[J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2016, 16 (05) : 345 - 357
[28] The past, present, and future of fenestrated/branched endovascular aortic repair
Hicks, Caitlin W.
Mendes, Bernardo C.
[J]. SEMINARS IN VASCULAR SURGERY, 2022, 35 (03) : 235 - 235
[29] Cell-based liver therapies: past, present and future
Iansante, Valeria
Chandrashekran, Anil
Dhawan, Anil
[J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2018, 373 (1750)
[30] Evolution of therapies for the corneal endothelium: past, present and future approaches
Ong, Hon Shing
Ang, Marcus
Mehta, Jodhbir S.
[J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2021, 105 (04) : 454 - 467

← 1 2 3 4 5 →